|
2022
|
Invention
|
Method of adjuvant cancer treatment.
The present invention provides a method of providing adjuva... |
|
|
Invention
|
Process for concentration of antibodies and therapeutic products thereof. This present disclosure... |
|
|
Invention
|
Compositions and methods for treatment.
The present invention provides compounds and methods for... |
|
|
Invention
|
Amorphous solid form of compounds containing s—n-valeryl-n- {[2′-( 1 h-tetrazole-5-yl)-biphenyl-4... |
|
|
Invention
|
Ribociclib tablet. The present disclosure is directed to oral tablet of ribociclib including its ... |
|
|
Invention
|
Amorphous solid form of compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl... |
|
2021
|
Invention
|
Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r... |
|
|
Invention
|
Pharmaceutical use.
The present invention relates to novel methods and pharmaceutical compositio... |
|
|
Invention
|
Lfa-1 inhibitor formulations.
The present invention provides formulations, methods and kits for ... |
|
|
Invention
|
Crystalline pharmaceutical and methods of preparation and use thereof.
Novel crystalline polymor... |
|
2020
|
Invention
|
Modulators of cellular adhesion.
The present invention provides compounds having formula (I):
... |
|
2019
|
Invention
|
Method of adjuvant cancer treatment. The present invention provides a method of providing adjuvan... |
|
|
Invention
|
Amorphous solid form of compounds containing s—n-valeryl-n-{[2′-(1h-tetrazole-5-yl)-biphenyl-4-yl... |
|
|
Invention
|
Eltrombopag dosing regimen. The present invention relates to a method of treating immune thromboc... |
|
2018
|
Invention
|
Dosage regimen of an s1p receptor modulator. The present invention relates to a dosage regimen of... |
|
|
Invention
|
Inhibitors for treating diseases characterized by atrial enlargement or remodeling. The present i... |
|
2016
|
Invention
|
Treatment of solid tumors with rapamycin derivatives.
Rapamycin derivatives have interesting eff... |
|
|
Invention
|
Sacubitril-valsartan dosage regimen for treating heart failure. The present invention relates to ... |
|
2015
|
Invention
|
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-car... |
|
|
Invention
|
High concentration antibody and protein formulations. The present application relates to highly c... |
|
1991
|
G/S
|
antihypertensive |
|
1989
|
G/S
|
ANTIHYPERTENSIVE |
|
1979
|
G/S
|
Antihypertensive |
|
1976
|
G/S
|
ANTI-HYPERTENSIVE PREPARATION |
|
1950
|
G/S
|
PREPARATION RECOMMENDED FOR THE TREATMENT OF HEADACHES |
